Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of 77.8% against symptomatic Covid-19 in phase 3 clinical trials. Efficacy analysis of the Bharat Biotech vaccine showed that it was 93.4% effective against severe symptomatic Covid-19. Against asymptomatic Covid-19, the […]